AAAAAA

   
Results: 1-8 |
Results: 8
Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis
Authors: Viguier, A le Traon, AP Massabuau, P Valton, L Larrue, V
Citation: A. Viguier et al., Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis, J NEUROL, 248(9), 2001, pp. 768-771
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator - A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
Authors: Larrue, V von Kummer, R Muller, A Bluhmki, E
Citation: V. Larrue et al., Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator - A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II), STROKE, 32(2), 2001, pp. 438-441
Guidelines for intravenous thrombolytic therapy in stroke victims
Authors: Larrue, V Amarenco, P Caussanel, JP Ducrocq, X Lucas, C Mahagne, MH Rouanet, F Baron, JC Baumelou, B Bouillat, J Bousser, MG Bracard, S Chopard, JL Dechy, H Ellie, E Giroud, M Goldstein, P Hinault, P Hommel, M Leys, D Maiza, D Mas, JL Masson, C Moulin, T Mounier-Vehier, F Rancurel, G Trouillas, P Leys, D Castel, JP Branchereau, A
Citation: V. Larrue et al., Guidelines for intravenous thrombolytic therapy in stroke victims, PRESSE MED, 29(7), 2000, pp. 372-378
Recommendations for using intravenous fibrinolysis in stroke patients
Authors: Larrue, V Amarenco, P Caussanel, JP Ducrocq, X Lucas, C Mahagne, MH Rouanet, F Baron, JC Baumelou, B Boulliat, J Bousser, MG Bracard, S Castel, JP Chopard, JL Dechy, H Ellie, E Giroud, M Goldstein, P Hinault, P Hommel, M Leys, D Maiza, D Mas, JL Masson, C Moulin, T Mounier-Vehier, F Rancurel, G Trouillas, P Branchereau, A
Citation: V. Larrue et al., Recommendations for using intravenous fibrinolysis in stroke patients, REV NEUROL, 156(12), 2000, pp. 1178-1185
ECASS-II: intravenous alteplase in acute ischaemic stroke - Reply
Authors: Hacke, W Davalos, A von Kummer, R Kaste, M Larrue, V ECASS II Study Grp
Citation: W. Hacke et al., ECASS-II: intravenous alteplase in acute ischaemic stroke - Reply, LANCET, 353(9146), 1999, pp. 67-68
Early ischemic recurrence and microembolic signals detected by transcranial Doppler - Response
Authors: Valton, L Larrue, V
Citation: L. Valton et V. Larrue, Early ischemic recurrence and microembolic signals detected by transcranial Doppler - Response, STROKE, 30(6), 1999, pp. 1290-1291
Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator
Authors: Manelfe, C Larrue, V von Kummer, R Bozzao, L Ringleb, P Bastianello, S Iweins, F Lesaffre, E
Citation: C. Manelfe et al., Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator, STROKE, 30(4), 1999, pp. 769-772
Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
Authors: Fiorelli, M Bastianello, S von Kummer, R del Zoppo, GJ Larrue, V Lesaffre, E Ringleb, AP Lorenzano, S Manelfe, C Bozzao, L
Citation: M. Fiorelli et al., Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort, STROKE, 30(11), 1999, pp. 2280-2284
Risultati: 1-8 |